Drug
Sisunatovir clinical trials
Also written RV521 and PF-07923568.
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
13 studies that test it; most in 2023 (8)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 8 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 0
Studies
Open first, then newest update. How each study uses sisunatovir is read from its arms, and is right about nine times in ten.
Testing it · 13
- A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) InfectionTerminatedPhase 2/3PfizerNCT06079320Written as Sisunatovir
- A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) InfectionCompletedPhase 2PfizerNCT03258502Written as RV521
- A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.CompletedPhase 1PfizerNCT05994963Written as sisunatovir
- A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults.CompletedPhase 1PfizerNCT06105983Written as Sisunatovir
- A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.CompletedPhase 1PfizerNCT05857644Written as PF-07923568
- A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.CompletedPhase 1PfizerNCT05987072Written as Sisunatovir
- A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.CompletedPhase 1PfizerNCT05878522Written as sisunatovir
- A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.TerminatedPhase 2PfizerNCT04225897Written as RV521
- A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult ParticipantsCompletedPhase 1PfizerNCT05712460Written as sisunatovir
- A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney FunctionCompletedPhase 1PfizerNCT06037031Written as Drug: PF-07923568
- Pharmacokinetics and Safety of RV521 FormulationsCompletedPhase 1PfizerNCT04065698Written as RV521
- A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult ParticipantsCompletedPhase 1PfizerNCT03782662Written as RV521
- Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSVWithdrawnPhase 2PfizerNCT04267822Written as RV521 oral tablet
Codes
What other systems call sisunatovir · ClinicalTrials.gg INT001643
- MeSH (NLM) C000717948sisunatovirOne source NLM
- UNII (FDA) KE63TTO7WKSISUNATOVIRConfirmed FDA, NLM, Wikidata
- Wikidata Q116011543sisunatovirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C170818SisunatovirOne source FDA
- DrugBank DB15674One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000717948 | sisunatovir | One source NLM |
| UNII (FDA) | KE63TTO7WK | SISUNATOVIR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q116011543 | sisunatovir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C170818 | Sisunatovir | One source FDA |
| DrugBank | DB15674 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.